A detailed history of National Asset Management, Inc. transactions in Novo Nordisk A S stock. As of the latest transaction made, National Asset Management, Inc. holds 59,506 shares of NVO stock, worth $7.19 Million. This represents 0.22% of its overall portfolio holdings.

Number of Shares
59,506
Previous 53,996 10.2%
Holding current value
$7.19 Million
Previous $6.93 Million 22.5%
% of portfolio
0.22%
Previous 0.16%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 19, 2024

BUY
$122.71 - $146.91 $676,132 - $809,474
5,510 Added 10.2%
59,506 $8.49 Million
Q1 2024

May 16, 2024

BUY
$102.11 - $135.92 $328,692 - $437,526
3,219 Added 6.34%
53,996 $6.93 Million
Q4 2023

Mar 15, 2024

SELL
$87.78 - $105.45 $282,563 - $339,443
-3,219 Reduced 5.96%
50,777 $5.25 Million
Q3 2023

Dec 01, 2023

BUY
$90.94 - $199.54 $2.9 Million - $6.37 Million
31,914 Added 144.52%
53,996 $4.91 Million
Q2 2023

Jul 27, 2023

BUY
$155.98 - $172.65 $233,190 - $258,111
1,495 Added 7.26%
22,082 $3.57 Million
Q1 2023

May 17, 2023

SELL
$132.34 - $159.14 $174,688 - $210,064
-1,320 Reduced 6.03%
20,587 $3.28 Million
Q4 2022

Feb 21, 2023

SELL
$102.55 - $135.33 $245,094 - $323,438
-2,390 Reduced 9.84%
21,907 $2.96 Million
Q3 2022

Nov 14, 2022

BUY
$95.28 - $116.93 $424,662 - $521,157
4,457 Added 22.46%
24,297 $2.42 Million
Q2 2022

Aug 12, 2022

BUY
$103.24 - $121.81 $137,722 - $162,494
1,334 Added 7.21%
19,840 $2.21 Million
Q1 2022

May 02, 2022

BUY
$93.1 - $112.54 $1,210 - $1,463
13 Added 0.07%
18,506 $2.06 Million
Q4 2021

Jan 28, 2022

BUY
$95.88 - $117.08 $59,253 - $72,355
618 Added 3.46%
18,493 $2.07 Million
Q3 2021

Nov 16, 2021

BUY
$84.42 - $106.62 $12,072 - $15,246
143 Added 0.81%
17,875 $1.7 Million
Q2 2021

Aug 10, 2021

SELL
$67.66 - $84.76 $8,660 - $10,849
-128 Reduced 0.72%
17,732 $1.47 Million
Q1 2021

May 13, 2021

BUY
$67.06 - $75.82 $1.2 Million - $1.35 Million
17,860 New
17,860 $1.2 Million

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $273B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track National Asset Management, Inc. Portfolio

Follow National Asset Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of National Asset Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on National Asset Management, Inc. with notifications on news.